Pennsylvania researchers have discovered that a sizable percentage of patients potentially at risk for cancer would turn down testing to uncover genes linked to the disease. While their study named cost as the most likely reason, a number of other factors could influence individuals to nix the tests.
View the original article here: Patients Nix Genetic Tests Due to Cost: Study
 |
Infographics | More... |
30 years later in Romania: What happened to the babies deprived of human contact? 
Is tilapia a human-made freak that we should avoid — or an evolutionary rockstar? 
Evolution’s ‘great leap forward’: When did humans cross the intelligence rubicon? 
How microplastics impact our food and our health 
Viewpoint: Regenerative agriculture has many different definitions. Here are 5 main principles — and whether they stand up to scrutiny 
Embryos aren’t female by ‘default’ after all, study shows 
Viewpoint: Agribashing and the French media — Paper withdraws ‘fake news’ viral article claiming drinking water contains 200 ‘dangerous’ chemicals 
Puppy love: When did the ‘unique and deeply ancient role of dogs as human companions’ begin? 
Why is it so difficult to find a treatment for Huntington’s Disease? 
Gene-edited chickens could reduce the threat of bird flu spread and promote sustainability 
